Alchemab Therapeutics Ltd logo

Alchemab Therapeutics Ltd

Pioneering Patient-led Antibody Therapeutics

71 employees · est. 2019 · London, United Kingdom

VS
XBiotech USA, Inc. logo

XBiotech USA, Inc.

Next Generation Antibody Therapy

97 employees · est. 2005 · Austin, United States

XBiotech USA, Inc. is the older company (2019 vs 2005).

Side-by-Side Comparison

Alchemab Therapeutics Ltd XBiotech USA, Inc.
Founded
2019 2005 older
Headquarters
London, United Kingdom Austin, United States
Employees
71 97
Industry
Biotechnology, Pharmaceutical Biotechnology, Health Care
Funding Stage
Series A Not tracked yet
Total Funding
$145.82M Not tracked yet
Funding Rounds
8 Not tracked yet
Services
Development of antibody therapeutics, Conducting clinical trials, Biopharmaceutical partnerships, Deep learning in drug development Not tracked yet
Target Customers
Healthcare providers, Pharmaceutical companies, Cancer research organizations, Biotech investors Not tracked yet
Taxonomy
Antibody Therapeutics, Patient-led Drug Discovery, Natural Protective Antibodies, Immunology, Hard-to-treat Diseases, Oncology Biotech, Neurodegenerative Diseases, Infectious Diseases, Biobank Collaboration, Function-first Approach, Innovative Drug Development, Biopharmaceutical Research, Collaborative Research, Biotech Disease Prevention Biopharmaceuticals, Antibody Therapy, True Human™ Antibodies, Oncology, Inflammatory Conditions, Infectious Diseases, Clinical Trials, Drug Development, Therapeutic Antibodies, Immunotherapy, Precision Medicine, Disease Treatment, Medical Research, Immunology
Website
alchemab.com xbiotech.com
Alchemab Therapeutics Ltd logo

About Alchemab Therapeutics Ltd

Alchemab Therapeutics Ltd, founded in 2019 and headquartered in the United Kingdom, is at the forefront of harnessing the natural power of patient antibodies to tackle hard-to-treat diseases. Their slogan, "Pioneering Patient-led Antibody Therapeutics," encapsulates their innovative approach in the...

XBiotech USA, Inc. logo

About XBiotech USA, Inc.

XBiotech USA, Inc. is a pioneering global biosciences company specializing in the discovery, development, and commercialization of therapeutic antibodies using its True Human™ proprietary technology. Unlike traditional antibody therapies, XBiotech’s True Human™ antibodies are derived from individual...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Alchemab Therapeutics Ltd and XBiotech USA, Inc. — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Alchemab Therapeutics... and XBiotech USA, Inc. — by email.

Frequently Asked Questions

Alchemab Therapeutics Ltd — Pioneering Patient-led Antibody Therapeutics . XBiotech USA, Inc. — Next Generation Antibody Therapy. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Alchemab Therapeutics Ltd has raised $145.82M while XBiotech USA, Inc. has raised undisclosed funding.
Alchemab Therapeutics Ltd and XBiotech USA, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Alchemab Therapeutics Ltd with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy